Attovia Therapeutics, Inc. ATTO
IPO $22.86 -$0.80-3.38% NASDAQ
IPO Score
IPO Date
Aug 04, 2026
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2026 06/30/2025
Total Cash And Short-Term Investments -13.19% --
Total Receivables 28.57% --
Inventory -- --
Prepaid Expenses -28.64% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets -13.35% --

Total Current Assets -13.35% --
Net Property, Plant & Equipment -7.60% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 54.86% --
Total Assets -12.14% --

Total Accounts Payable 137.42% --
Total Accrued Expenses -5.53% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 3.03% --
Total Finance Division Other Current Liabilities -- --
Total Other Current Liabilities -- --
Total Current Liabilities 28.74% --

Total Current Liabilities 28.74% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -19.04% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -9.60% --
Total Liabilities 16.49% --

Common Stock & APIC 19.03% --
Retained Earnings -15.95% --
Treasury Stock & Other -192.59% --
Total Common Equity -15.89% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 0.00% --
Preferred Stock, Others -- --
Total Preferred Equity 0.00% --

Total Common Equity -15.89% --
Total Preferred Equity 0.00% --
Total Minority Interest -- --
Total Equity -15.03% --